The American Glaucoma Society and the American Academy of Ophthalmology have jointly addressed the difficulties glaucoma patients face in accessing eye drop medications due to restrictive pharmacy benefit plans. Issues like early refill denials, high copays, and complex formulary management hinder treatment adherence, risking vision loss. They urge health insurers to reassess their policies to enhance medication access and prevent complications related to glaucoma.